A new entity for the negotiation of public procurement prices for patented medicines in Mexico.
about
Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countriesUnderstanding the dynamics of the Seguro Popular de Salud policy implementation in Mexico from a complex adaptive systems perspective.Policy approaches to improve availability and affordability of medicines in Mexico - an example of a middle income country.Prescription patterns of antihypertensives in a community health centre in Mexico City: a drug utilization study.A review of promoting access to medicines in China - problems and recommendations.Access to innovative cancer medicines in a middle-income country - the case of Mexico
P2860
A new entity for the negotiation of public procurement prices for patented medicines in Mexico.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A new entity for the negotiati ...... patented medicines in Mexico.
@ast
A new entity for the negotiati ...... patented medicines in Mexico.
@en
type
label
A new entity for the negotiati ...... patented medicines in Mexico.
@ast
A new entity for the negotiati ...... patented medicines in Mexico.
@en
prefLabel
A new entity for the negotiati ...... patented medicines in Mexico.
@ast
A new entity for the negotiati ...... patented medicines in Mexico.
@en
P2093
P2860
P356
P1476
A new entity for the negotiati ...... patented medicines in Mexico.
@en
P2093
Maki Ortiz
Octavio Gómez-Dantés
Paulina Terrazas
P2860
P304
P356
10.2471/BLT.12.106633
P407
P577
2012-08-22T00:00:00Z